Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

UCB SA

UCBJYPNK
Healthcare
Biotechnology
$146.67
$0.002(0.001%)
U.S. Market opens in NaNh NaNm

UCB SA (UCBJY) Stock Overview

Explore UCB SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap53.8B
P/E Ratio30.02
EPS (TTM)$4.61
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$125.82
3 Months$158.02
1 Year Target$179.52

UCBJY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of UCB SA (UCBJY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $179.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.02 and a market capitalization of 53.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.76%
5-Day Change
-3.32%
1-Month Change
-13.48%
3-Month Change
0.10%
6-Month Change
18.04%
Year-to-Date (YTD) Change
2.75%
1-Year Change
45.30%
3-Year Change
239.33%
5-Year Change
191.05%
All-Time (Max) Change
841.07%

Contact Information

32 2 559 99 99
Allée de la Recherche, 60, Brussels, NaN, 1070

Company Facts

90,520 Employees
IPO DateAug 3, 2012
CountryBE
Actively Trading

Frequently Asked Questions